Pure Global

CERULOPLASMIN - ANVISA Registration 10345162354

Access comprehensive regulatory information for CERULOPLASMIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10345162354 and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS, INC. - EUA. The registration is held by SIEMENS HEALTHCARE DIAGNร“STICOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, SENTINEL CH. SPA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
10345162354
Registration Details
ANVISA Registration Number: 10345162354
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Ceruloplasmina Reagente
Risk Class II

Registration Details

10345162354

25351317331201945

01449930000190

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMร‰RICA

Dates and Status

Apr 06, 2020

VIGENTE

09/18/2025 19:00:01